POPULARITY
144 episodes with Gelfand
55 episodes with Gelfand
6 episodes with Gelfand
4 episodes with Gelfand
4 episodes with Gelfand
3 episodes with Gelfand
2 episodes with Gelfand
3 episodes with Gelfand
3 episodes with Gelfand
In this episode of Inside GRAPPA, Dr. Joel Gelfand joins host Mio Nakamura to discuss a groundbreaking pragmatic trial that may transform access to phototherapy. A long-standing GRAPPA member and trailblazer in dermatologic research, Dr. Gelfand shares insights from the "LITE Study," a patient-centered, nationwide trial comparing home-based vs. office-based phototherapy for psoriasis.You'll hear: • Why phototherapy remains a preferred treatment for many patients, even in the biologic era • Surprising results comparing office phototherapy to adalimumab (a biologic) in previous trials • How skin of color patients may benefit most from home phototherapy---and why • Real-world barriers to accessing phototherapy and how the study tackled them head-on • What's next: From research findings to implementation science and changing payer coverageThis episode is essential listening for dermatologists, rheumatologists, and researchers passionate about improving access and outcomes for patients with psoriatic disease. Tune in for a conversation that blends clinical science with patient advocacy---and may reshape the standard of care.
In part 1 of this two part episode, Stacey Richter speaks with James Gelfand, President and CEO of the ERISA Industry Committee (ERIC), about the potential effects of proposed Medicaid cuts on plan sponsors and their members. They explore ways plan sponsors can prepare for the changes, including Medicaid's four major areas of possible cuts: reducing waste, fraud, and abuse; implementing work requirements; reeling in provider taxes; and addressing the 'Cornhusker Kickback' from the ACA. The conversation also delves into how state governments and hospitals might respond to these cuts and suggests actions for plan sponsors to mitigate potential impacts. The episode is part one of a two-part series, with the second episode covering Medicare site neutral payments and HSA reforms. === LINKS ===
In part 2 of episode 469, host Stacey Richter discusses the implications of Medicare site neutral payments and Health Savings Account (HSA) reforms with James Gelfand, president and CEO of the ERISA Industry Committee (ERIC). The episode details how plan sponsors should adapt to Medicare's site neutral payment policies aimed at curbing hospital consolidation and inflated prices through facility fees and markups. Gelfand provides insights into how HSA reforms currently in Congress could expand the scope of preventive care covered before deductibles are met, benefitting both employers and employees. The conversation also touches on the challenges high deductible health plans pose and the potential benefits of codifying recent IRS guidance to allow greater flexibility in pre-deductible coverage. The discussion underscores the importance of plan sponsors staying ahead of Medicare policies to avoid higher costs. === LINKS ===
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, The Loop's Kevin Cusick, and psychic Ruth Lordan.
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, The Loop's Kevin Cusick, and psychic Ruth Lordan.
Welcome to another episode of The Barber's Brief! Join Marc and Vassilis as they dive into the latest marketing and business news, spotlight a standout case study in their Marketing Moment, and wrap up with the Ad of the Week. This week though, they tackle the topic of the potential trade war that could be looming! Enjoy the show! Follow our updates here: https://www.linkedin.com/company/sleeping-barber/ Get in touch with our hosts: Marc Binkley: https://www.linkedin.com/in/marcbinkley/ Vassilis Douros: https://www.linkedin.com/in/vassilisdouros/ Timestamps: 00:00 - Introduction 01:39 - NBC Tariff Overview? 04:04 - Tariffs and the 4Ps 20:05 - The Marketing Moment: WARCs Multiplier Effect Study 29:22 - Ad of the Week - Kraft Mayonnaise from 1931 34:23 - Coming Up Next Week In The News Links Tariff Overview - NBC News NBC News https://www.nbcnews.com/politics/donald-trump/live-blog/trump-china-canada-mexico-tariffs-live-updates-rcna190144 Which provinces are pulling U.S. alcohol off shelves over Trump's tariffs? https://globalnews.ca/news/10993794/trump-tariffs-liquor-boards/ China's Massive Belt and Road Initiative https://www.cfr.org/backgrounder/chinas-massive-belt-and-road-initiative 10 things that could cost more under new tariffs https://www.fox9.com/news/trump-tariffs-price-hikes All the generic coronavirus ads are a waste of time and budget https://www.marketingweek.com/generic-covid-ads-waste-time-budget/ The Marketing Moment: WARC Multiplier Effect - Great resource with a few highly relevant case studies https://page.warc.com/the-multiplier-effect-report Ad Of The Week: An ad from Kraft in 1931 Despite a challenging economy, they didn't highlight the price Instead, Kraft focused on increasing brand recognition: from Gelfand to Kraft Product features & ingredients: a great supply chain that keeps mayonnaise Always Kitchen Fresh! Guaranteed by your trusted grocer Eggs, Select Oil, aged-in-the-wood vinegar, rare spices Service: Home Delivery Recipe ideas to use more: dress lettuce Emphasized nutritional value and quality for an economical price, and used recipe books as a promotional tool.
If there's one thing people who aren't kids hate, it's new slang. We discussed this yesterday, but considering this is Gelfand's last day as a weekly regular, we thought it best to teach him about Skibidi Toilet so he has something to mull over during his time off. Learn more about your ad choices. Visit podcastchoices.com/adchoices
We talk a lot about negativity in social media, but we don't talk nearly enough about how crappy ISPs are. Of course, we're not going to name any in the description here because we don't want to get sued, but Gelfand has some firsthand experience. Learn more about your ad choices. Visit podcastchoices.com/adchoices
In this milestone 100th episode of Derms and Conditions, host James Del Rosso, DO, takes listeners on a year-in-review journey through some of the greatest highlights from 2024. This special solo episode reflects on standout conversations with leading dermatologists and previews exciting plans for 2025. Dr Del Rosso revisits key insights from some of the most impactful episodes on this 100th Episode of Derms and Conditions Podcasts: Episode 91 with Dr Joel Gelfand explored psoriasis comorbidities and the importance of connecting with patients on both physical and mental health. Dr Gelfand emphasized the need for dermatologists to assess cardiovascular risks and encourage patients to engage with their broader medical team. Episode 89 with Dr Jessica Kaffenberger took a deep dive into hidradenitis suppurativa, including strategies to address disease chronicity, tackle psychosocial aspects, weight and smoking challenges tactfully, initiating biologic agents early to halt disease progression before permanent sequelae markedly increase and specific tips for using intralesional corticosteroids and infliximab infusion for severe cases. Episode 96 with Dr David Cotter explored the art and science of patch testing, especially for patients with atopic dermatitis who may have concurrent allergic contact dermatitis. Dr Cotter shared practical advice on tailoring patch testing and considerations regarding ongoing medications used to treat atopic dermatitis. Episode 90 with Dr Jason Hawkes took a closer look at TYK2 inhibition with deucravacitinib, highlighting its novel allosteric mechanism, its more selective pathway inhibition, and 4-year safety and efficacy data. Episode 97 with Dr Tina Bhutani provided insights on newer nonsteroidal topicals like roflumilast and tapinarof, including tips for integrating these agents with corticosteroids and using them under occlusion for thicker lesions. With so many exceptional episodes in 2024 and exciting plans ahead, listeners can look forward to even more cutting-edge insights in 2025. Don't miss any of these conversations—catch up anytime at dermsquared.com/podcasts/derms-and-conditions
On this episode of the Cannacurio Podcast, Ed Keating chats with Brett Gelfand, founder of CannaBIZ Collects and the Cannabiz Credit Association. They discuss Brett's journey from Colorado's cannabis market to pioneering solutions for credit and collection challenges in the industry. Learn how these organizations are transforming financial practices by leveraging data and collaboration to drive smarter credit decisions and foster business stability. Tune in for insights on navigating the industry's financial complexities and predictions for its future. Head over to http://www.cannabiz.media/cannacurio for a full transcription and find us on social media for more clips of new and upcoming episodes. Visit http://www.cannabiz.media to join thousands of reputable companies from around the world who are engaging and connecting with the cannabis and hemp industry! You can also find the Cannacurio Podcast on Apple Podcasts, Spotify, and iHeartRadio.
Dr. Michele Gelfand is a cultural psychologist and author of Rule Makers, Rule Breakers. She joins us to discusses how “tight” and “loose” cultures shape societies. Tight cultures, like Japan's, respond to threats with strict rules and order, while looser ones, like the U.S., allow greater flexibility. Gelfand suggests a balanced “Goldilocks” approach, adjusting strictness and flexibility to suit each environment's needs, from families to organizations. She also explores online accountability, recommending "nudges" to promote civility, and sees AI as a potential tool for managing biases and promoting understanding. Guest Bio Michele Gelfand is a Professor of Organizational Behavior at the Stanford Graduate School of Business and Professor of Psychology by Courtesy at Stanford University. Gelfand uses field, experimental, computational, and neuroscience methods to understand the evolution of culture--as well as its multilevel consequences for human groups. Her work has been cited over 20,000 times and has been featured in the Washington Post, the New York Times, the Boston Globe, National Public Radio, Voice of America, Fox News, NBC News, ABC News, The Economist, De Standard, among other outlets. Gelfand has published her work in many scientific outlets such as Science, the Proceedings of the National Academy of Sciences, Proceedings of the Royal Society B, Psychological Science, Nature Scientific Reports, PLOS 1, the Journal of Personality and Social Psychology, Organizational Behavior and Human Decision Processes, Academy of Management Review, Academy of Management Journal, Research in Organizational Behavior, Journal of Applied Psychology, Annual Review of Psychology, American Psychologist, Journal of Cross-Cultural Psychology, Current Opinion in Psychology, among others. She has received over 13 million dollars in research funding from the National Science Foundation, Department of Defense, and the FBI. As a native New Yorker, Michele is now a California transplant. She is married to Todd Betke and has two daughters, Jeanette and Hannah, two birds (Bonnie and Theo) and a Portuguese water dog, Pepper. Show Notes (1:47) What is culture? (4:08) The age that we start learning norms (10:01) What makes a person or nation a tight versus a loose culture (15:12) How the movement of people affect looseness and tightness dynamics (17:57) How changes in attitudes occur (20:59) Tightness doesn't mean a lack of creativity (24:26) The Goldilocks Approach (30:49) Avoiding becoming too tight or too loose (32:55) Applying the Goldilocks Approach on social media (35:56) The disrupting force technology can have on loose and tight cultures (38:19) AI's ability to understand culture (41:11) What's next for Dr. Michele Gelfand (45:00) How to follow Michele's work Links Referenced Values, Political Action, and Change in the Middle East and the Arab Spring: https://www.amazon.com/Values-Political-Action-Change-Middle/dp/019026909X Rule Makers, Rule Breakers: How Tight and Loose Cultures Wire Our World: https://www.amazon.com/Rule-Makers-Breakers-Tight-Cultures/dp/1501152939 Personal website: michelegelfand.com
In episode 615, Megan chats to Elan Gelfand about the importance of focus, discipline, consistency, handling judgment, and reigniting passion. Elan Gelfand started the podcast Abundant Thinking where he talks about how to live a purposeful life and how to improve your mindset. Elan has spoken to some of the best coaches in their industry and has valuable insight on how to succeed and how to cultivate a bulletproof mindset. In this episode, you'll learn about creating the right environment to minimize distractions, building discipline slowly to achieve long-term success and adopting a mindset of not caring about others' opinions. Key points discussed: - Start small to build discipline: Begin with small, achievable goals and gradually increase the difficulty, rather than setting unrealistic high expectations that are hard to maintain. - Eliminate distractions: Use tools like the Opal app to block distracting apps and create an environment conducive to focused work. - Consistency leads to discipline: Staying consistent with your habits, even in small ways, can help develop long-term discipline. - Reframe judgment: When faced with judgment from others, remember that people who are doing well are unlikely to waste time criticizing you. - Focus on your own approval: Prioritize your own self-approval over the opinions of others, as you'll be spending the most time with yourself. - Reignite passion by trying new things: Experiment with different aspects of your work to find new sources of inspiration and excitement. - Appreciate the good times: Recognize and be grateful for the moments when you feel passionate and engaged, as they can help you push through the more challenging periods. - Differentiate between focus and discipline: Focus is about staying committed in the moment, while discipline is about consistently doing the same thing over time. - Create the right environment: Deliberately set up your physical and digital surroundings to support your productivity and minimize distractions. - Limit time with negative people: Reduce interactions with those who are judgmental or unsupportive, and instead seek out positive, encouraging relationships. Connect with Elan Gelfand Spotify| Instagram
Welcome to the new iteration of my podcast! I'm calling it Inspired! with me, your host, Kiersten Gelfand. We'll still be talking about wellness and fitness a lot of the time, but I wanted to broaden the subject of the podcast to encapsulate all different kinds of inspiring subjects. I'm so excited to begin this new chapter and I hope you'll follow along!
You've heard Gelfand talk about the good old days at the Star. Or the Tribune. Whichever one it was. Dave Nimmer was also there for those days, and also the ones Tom remembers which involve significantly less typing. Learn more about your ad choices. Visit podcastchoices.com/adchoices
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, The Loop's Kevin Cusick, and psychic Ruth Lordan.
Tim and Tony remain for a more informal discussion of the world and the people who live in it, none of whom are doing voice acting work. Not a lot of them are doing standup comedy either. Could it be that times are still a-changin'? Even though we asked them politely not to? Learn more about your ad choices. Visit podcastchoices.com/adchoices
In this episode of Derms and Conditions, host Dr James Q. Del Rosso welcomes Dr Joel M. Gelfand, Professor of Dermatology and Epidemiology at the University of Pennsylvania, to explore the critical issue of comorbidities in dermatology, with a focus on psoriasis, and address why dermatologists should take an active role in recognizing and addressing these risks. Dr Gelfand reflects on his early observations of patients with psoriasis and their potential internal health issues, noting how in the past, psoriasis was primarily seen as just a skin condition. However, research and a pivotal article on inflammatory pathways in atherosclerosis led to improved understanding that psoriasis is linked to cardiovascular disease. Dr Gelfand then discusses the groundbreaking use of electronic medical records to track patients with psoriasis over time, revealing higher incidences of cardiovascular events and mortality. This research highlighted that people with moderate to severe psoriasis have a reduced life expectancy by about 5 years, underscoring the need for dermatologists to address comorbidities in their patients. The conversation then explores practical advice for clinicians, focusing on the role of dermatologists in identifying cardiovascular and diabetes risks in patients with psoriasis. Dr Gelfand suggests a simple yet effective approach: educate patients about their increased health risks, perform basic screenings like cholesterol and blood pressure checks, and collaborate with primary care physicians or cardiologists when needed. By fostering multidisciplinary care, dermatologists can play a crucial role in preventing life-threatening conditions in their patients. Tune in to the full episode for guidance on addressing the broader health risks associated with psoriasis and the practical steps dermatologists can take to help reduce these risks. From screening for cardiovascular disease to forming strong collaborations with other health care providers, this episode offers valuable insights for improving patient outcomes.
Of course, we can't have Tom and Gelfand in the same room and NOT talk about politics but here is the best part.....they don't agree on everything, but they left as friends. See people, we can do it. Anything is possible if you put your mind to it. Someone should tell that to the twins. Apparently they missed that memo cause the only thing they are doing is the impossible...A Winning Minnesota Sports Team Learn more about your ad choices. Visit megaphone.fm/adchoices
On the 24th, Tom was at the State Fair along with Hubbard, and he even decided to record a show there. Hey, more unusual things have happened. For example, the whole family did a show at the state fair many years ago. Now if that happens again you can probably assume the rapture is coming. Learn more about your ad choices. Visit megaphone.fm/adchoices
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, The Loop's Kevin Cusick, and psychic Ruth Lordan.
Welcome to Grit & Growth's masterclass on cross-cultural dynamics with Michele Gelfand, Stanford Graduate School of Business professor in organizational behavior. Gain new insights and strategies for understanding your company's culture – from tight to loose – and how you can use that knowledge to build cultural intelligence in your organization, navigate interactions, enhance company-wide innovation, and drive business growth. Companies and countries can be a lot like people. Some are tight. Others are loose. Neither is inherently good or bad, according to Michele Gelfand, a leading expert on the impact of organizational culture and the best-selling author of Rule Makers, Rule Breakers: How Tight and Loose Cultures Wire Our World. Gelfand says this important and often invisible force can drive behavior and ultimately performance – which is why she finds the subject so fascinating and why she believes entrepreneurs should pay attention to culture as they build their leadership and business.Key Takeaways Culture matters“If we don't understand culture, we're putting ourselves and our businesses at risk. All cultures have rules, and they're really one of our best inventions because they help us predict each other's behavior and coordinate. They're the glue that keeps us together.”Tight vs. Loose“Tight cultures have strict rules and very reliable punishments for when you deviate from rules. They restrict the range of behavior that's permissible in any context. Loose cultures have weaker rules, their wider range of behavior that's permissible.”Strive for flexible tightness“Loose cultures are more creative, but they don't necessarily scale up. Tighter cultures are better able to implement and scale up, but they're not as good at coming up with these really novel ideas. And so the big trick here is: How do you bring together both of these elements?”Watch out for resistance to cultural change“Try to balance accountability and empowerment, but pay close attention to pushback. Extreme change can be very threatening for people's sense of control, predictability, and order that's really needed in these contexts. And what we know is that we need to manage these sources of resistance.” Listen to Michele Gelfand's advice to entrepreneurs for creating culturally ambidextrous organizations and learn more about her future research. Don't forget to take Gelfand's quiz for determining where you and your team fall on the tight/loose spectrum.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, The Loop's Kevin Cusick, and psychic Ruth Lordan.
Mike "Gelfand" Gelfand has been a regular on the show for some time now. But can you believe that this wasn't always the case? It's true. While he was there since nearly the beginning, it was a rare event, like a shooting star. Or in this case, a euphemising star. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode, I explore the role of phototherapy in treating psoriasis and how it compares to the more commonly discussed biologics. I'm joined by Dr. Joel Gelfand, the Director of the Center for Clinical Sciences in Dermatology and Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania's Perelman School of Medicine. Dr. Gelfand has made significant contributions to our understanding of phototherapy's effectiveness for psoriasis patients. Together, we delve into the nuances of how phototherapy works, its benefits, and its place in modern dermatological care. Tune in to gain valuable insights from our conversation. Connect with me across Social: Instagram:https://www.instagram.com/drhannahkopelman/ TikTok: https://www.tiktok.com/@drhankopelman Twitter: https://twitter.com/drhankopelman Pinterest: https://www.pinterest.com/drhankopelman/ Personal Site: https://www.hannahkopelman.com The content of this podcast is for entertainment and educational purposes only. This content is not meant to be a substitute for medical advice or treatment for any medical condition. --- Send in a voice message: https://podcasters.spotify.com/pod/show/hannah-kopelman/message
Chris Scott interviews Howie Gelfand as we learn his story, his recovery journey, and the real story behind the Wolf of Wall Street!
The landscape of options for treating people with kidney failure is shifting. It used to be that the “only” robust option in the US was dialysis. You can listen to our prior podcast with Keren Ladin talking about patients who viewed dialysis as their only option, and structural issues that led to this point (including this takedown of for profit dialysis companies by John Oliver). One of the problems was a lack of an alternative robust option to offer patients. As one of our guests says, you have to offer them something viable as an alternative to dialysis. Today we interviewed Sam Gelfand, dually trained in nephrology and palliative care, Kate Sciacca, a nurse practitioner (fellowship trained in palliative care), and Josh Lakin, palliative care doc, who together with a social worker and other team members started KidneyPal at DFCI/BWH, a palliative care consult service for people with advanced kidney disease. As a team, they provide a robust alternative to dialysis for patients with kidney failure: conservative kidney management. And “conservative,” as they note, can mean not only a “conservative approach,” as in non-invasive/less aggressive, but also an effort to “conserve” what kidney function remains. We get right down to the nitty gritty of kidney supportive care techniques they incorporate in clinic, including: Communication about the choice between dialysis and conservative kidney management: what are the tradeoffs? Function often declines after initiating dialysis, at least among nursing home residents. Dialysis may extend life, but those “additional” days are often spent in the hospital or dialysis, away from home. Symptoms are common in both options, though more anxiety and cramping in dialysis, more pruritus and nausea in conservative kidney management.. Introducing the idea of hospice early, at the time of diagnosis with kidney failure. Listen also to our prior podcast with Melissa Wachterman on hospice and dialysis. Approaches to treating fatigue Approaches to treating pain - the second most common symptom (!) - and the answer isn't tramadol (or tramadon't) - rather think buprenorphine patch or methadone, and how to dose gabapentin and pregabalin. Also, don't count out the NSAIDS! Approaches to treating itching/pruritus Approaches to treating nausea Our guests were deeply grateful to their colleagues Dr. Frank Brennan, Dr. Mark Brown, and clinical nurse consultant Elizabeth Josland of the renal supportive care team at St. George Hospital in Sydney, Australia (down under) for teaching them the ropes of palliative care in kidney failure. And we got to learn some new vocabulary, including the meaning of “chunder.” Enjoy! -@AlexSmithMD
In the most recent solo episode, I shared that a few changes are coming to the format of the STaR Coach Show, all of which are designed to enhance and improve the value to our audience. You'll start to see some of those in today's interview with Annie Gelfand, the co-creator and host of the Essence of Mastery Summit. She shares how the path of coaching mastery has the secret sauce it takes to help us be better human beings. If we want to change the world, we have to continue to grow in our coaching mastery! Join us to learn more!Annie Gelfand is a Master Certified Coach (credentialed by the International Coach Federation), Advanced Certified Mentor Coach, and MCC Assessor. Coaching since 1997, she founded the Wisdom Foundation, a humanitarian, philanthropic, community-based, not-for-profit service, as well as Radical Wisdom and Reach Coaching Mastery. A corporate “survivor,” Annie has an MBA, is a Certified Professional Co-Active Coach, Organizational and Relationship Systems and Teams Coach, and holds multiple holistic certifications. She is an avid lover of all things natural and nature, including pickleball, kayaking, swimming, biking, hiking, gardening, ping pong, and chess. Show Highlights:Coaches care deeply and want to make an impact in the world.Running a coaching business requires business savvy around accounting, marketing, sales, etc.The feeling is magic!The #1 problem for MCC applicants? Not doing their inner workAlignment eliminates static noise and confusion about our purpose.The trap we fall into when we compare ourselves to others. Show your gifts to the world!“You can't be a secret and a success at the same time!”How to identify and celebrate with your support communityDo the inner work and find your blind spots.It's NOT about the money!Masterful coaches are transparent, curious, confident, and unique.Resources:Connect with Annie Gelfand: Website, LinkedIn, and FacebookCheck out the 2024 Essence of Mastery Summit and use code “Meg” for $498 off the full summit price. (You can get 39 ICF CCEUs for $947!)Work with Meg! A few spots remain for the Fall STaR Coach Show Mentor Program! Visit the STaR Coach Show YouTube Channel!Explore past episodes and other resources at www.STaRcoachshow.com. Explore the STaR Coach Community and see what's available there for you!
4/15/24: Easthampton Mayor Nicole LaChapelle: schools, & policing. Joan Gelfand: "Outside Voices: A Memoir of the Berkeley Revolution". W. Mass author Mickey Rathbun: "The Real Gatsby George Gordon Moore: A Granddaughter's Memoir". Holly Gramazio (soon at the Odyssey): "The Husbands".
Headache is among the most common neurologic disorders worldwide. The differential diagnosis for primary and secondary headache disorders is broad and making an accurate diagnosis is essential for effective management. In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Amy Gelfand, MD, who served as the guest editor of the Continuum® April 2024 Headache issue. They provide a preview of the issue, which publishes on April 3, 2024. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Gelfand is an associate professor at Benioff Children's Hospitals, University of California San Francisco in San Francisco, California. Additional Resources Continuum website: ContinuumJournal.com Subscribe to Continuum and save 15%: continpub.com/Spring2024 More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Guest: @aagelfand Full transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, a companion podcast to the journal. Continuum Audio features conversations with the guest editors and authors of Continuum, who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article by clicking on the link in the Show Notes. Subscribers also have access to exclusive audio content not featured on the podcast. As an ad-free journal entirely supported by subscriptions, if you're not already a subscriber, we encourage you to become one. For more information on subscribing, please visit the link in the Show Notes. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum Lifelong Learning in Neurology. Today, I'm interviewing Dr Amy Gelfand, who recently served as Continuum's guest editor for our latest issue on headache disorders. Dr. Gelfand is a child neurologist at the University of California, San Francisco, where she is an associate professor of neurology, and she also happens to be Editor-in-Chief of the journal Headache. Dr Gelfand, welcome, and thank you for joining us today. Dr Gelfand: Thank you so much for having me. Dr Jones: Dr Gelfand, this issue is full of extremely helpful clinical descriptions and treatment strategies for headache disorders. With your perspective as the editor for this issue - and you've just read all these wonderful articles and edited these articles - what were you most surprised to learn? Dr Gelfand: I would say that the medication overuse headache article I think is where you'll find the most surprising content. This is an area in headache medicine that has been controversial. I think what we've got is new data - relatively new data, published in Neurology (in the Green Journal) in 2022 - the MOTS trial, showing that what we all thought was not necessarily true. In headache medicine, there was this mantra that, if somebody is overusing (too frequently using) a certain kind of headache acute medication, you've got to stop them; you've got to have them stop it completely before you can get them on a preventive treatment if you expect it to work. Turns out, in this trial, that's not the case. People were randomized to either stopping the overused acute medicine and starting a preventive versus continuing it and starting a new preventive, and they did equally well. I think that's really taught us that that dogma was not based in evidence (was not true), and what really matters is getting a patient started on an effective migraine preventive treatment. Dr Jones: Wow, that is really – that is kind of ground shaking, isn't it? That's going to change a lot of practices for a lot of neurologists out there. Do you think that's going to be well received, or has it been well received so far? Dr Gelfand: I think it has. I want it to get out there further, so I hope everybody will read in that chapter and really pick up on that piece. I think it's helpful for patients, too - that we don't necessarily need to disrupt what makes them feel like they're getting some acute, in-the-moment relief. We just need to make sure we're getting a good-quality migraine preventive therapy started. That's the most important thing. We don't necessarily need to ask them to change something about their acute treatment. Dr Jones: That's fantastic, and it certainly could make things a little more straightforward, I think for people who are helping patients manage this. To be honest with you, the term, “medication overuse” almost sounds like it's putting the onus on the patient a little bit. Dr Gelfand: It very much does sound that way. It is a very challenging term for a lot of reasons. And I agree with you that that's a problematic part of this whole terminology. Dr Jones: Well, just three minutes into the interview here and, Dr Gelfand, you've already changed people's practice. I think that's wonderful, and we'll look forward to reading that specific article in the issue. Again, from your view as a headache specialist and a leader in the field, what do you think the biggest debate or controversy is in headache medicine right now? Dr Gelfand: I think where we're really a little bit stuck in trying to figure out how to move forward is how to take care of patients who have continuous headache. It's not even really a fully defined term, but if you imagine a person who - they wake up, headache is present; it continues to be present throughout the entire day; they go to bed- it's still present; if they happen to wake up in the middle of the night to go to the bathroom, it's there then - it's just there all the time. It can be hard to imagine that situation is real - that somebody could have a headache that is continuously present for weeks, months - but this is true of some of our patients who have chronic migraine, our patients who have new, daily, persistent headache, certain other headache disorders. This entire group of patients who have continuous headache have historically been excluded from treatment trials, so our existing data don't necessarily generalize to how to treat their condition. And we need to change that, because this is a group that is arguably most in need of research, most in need of effective therapies. The question is how? Who exactly should be included in the inclusion criteria? And then, what are your outcome measures? Historically, in migraine treatment trials, we use headache days per month or migraine days per month. Days of headache per month may or may not be the right primary outcome measure for somebody who's starting from a point of continuous headache. Maybe more appropriate is, how many severe headache days you're having in a month, or how much disability you have from your headache disease. It's an area that's evolving and really does need to evolve, because this is a patient population that has been underserved in research thus far. Dr Jones: I learned that, I think, in reading one of the articles talking about continuous headache at onset – so, the headaches that are continuous from day one, which is, as I understand it, pretty uncommon. But really very little of the clinical trial data speak to how to care for those patients - is that right? Dr Gelfand: That is exactly right. And, epidemiologically, maybe not as common. But in a headache clinic, we certainly see patients who have had these headache disorders where it starts on one particular day, it becomes continuous within twenty-four hours of onset and has now been going for at least three months, and we would call that new, daily, persistent headache. Or equally commonly, people with chronic migraine where it ramped up over maybe a short to medium-long period to daily and continuous. And now they have been experiencing continuous headache for some number of months, if not longer. Dr Jones: This question may be a little bit of an unfair question. One of the challenges with headache is that, unlike some other areas of a diverse specialty of neurology, there aren't as many biomarkers as you might have for dealing with patients who have cerebral ischemia or neuromuscular disease. Do you find that that leads to more differences of opinion or more variability in diagnosis and management than you might see in other areas? Dr Gelfand: I'm so glad you asked that question. What I find that leads to is more stigma. Many of our patients are not believed, including by medical professionals who they've met before. People might think they are faking their symptoms, or that there's some sort of secondary gain, or this is something related to - they just don't know how to manage stress. This is a real problem for patients with migraine to be encountering so much stigma. As a headache medicine clinician, when I'm meeting a patient, oftentimes I need to make sure to acknowledge that, almost certainly, they've encountered that before. I need to reassure them that they're not going to be experiencing that in our headache clinic, and really try to undo some of that harm to be able to build trust that we're going to have a collaborative relationship moving forward - we're going to be a team; we're going to be determining the next steps in treatment together - and that I 100% believe them that the symptoms they are experiencing are real, are very challenging. Because migraine and other primary headache disorders are real neurologic diseases that can be quite severe. But because we have a paucity of biomarkers, it's hard for some people outside the field to recognize that. And that, I think, has been really difficult for patients historically. Dr Jones: So, a challenge for clinicians has become really more of a burden for patients. Dr Gelfand: Yes - well said. Dr Jones: Yeah. That's too bad, and maybe someday that will change, and probably can be approached from a couple of different directions, right? - from educating clinicians' perspective and also pursuing the science. This might be a related question, Dr Gelfand - what do you think the biggest misconception you've encountered in - I'm thinking mostly from the provider of the clinician community - what do you think the biggest misperception or misconception there is about patients who have headache and the management of those patients? Dr Gelfand: Well, I think it is tied in, in some way, to this notion that the patients are somehow causing their problem; that it's something about - well, I'm a child neurologist; I see adolescents and children – so, their parent is causing their problem because they're a helicopter mom or whatever it is, or they're just not managing stress in an appropriate way. I think that that is really an issue that patients are sort of handed from the medical community. Whereas if I step back and think about it, before 2018, no migraine-specific preventive therapies existed. We were borrowing from all other corners of medicine. We were borrowing from antihypertensives, antiseizure medicines, antidepressant medicines, but there was no actual migraine-specific therapy. Then came the monoclonal antibodies targeting CGRP (calcitonin gene-related peptide) - they're targeting either the ligand or the receptor. We now also have the oral forms that target the receptor, the gepants. So, we do have this one or two classes, depending on how you break that out, that are migraine-specific preventive therapies. But that's not enough for a complex disease like migraine - we need twenty of them. Look at epilepsy; there are probably twenty-plus antiseizure medicines, and yet, some patients still seize. Is that because they're anxious or stressed, or their mothers are too stressed? No - it's because some people have terrible epilepsy. And yet that same explanation has not been afforded to people with difficult migraine disease, that with just one class of migraine-specific preventive (or two, if you break out the monoclonals and the gepants) - that, somehow, they're supposed to have magically stopped with this treatment. That really doesn't make any sense. It's because we don't have enough effective therapies that they're still having difficult migraine - it's not because they're causing their disease. Dr Jones: Thank you - that's a great example. That is important to understand - that misconception about causation. And we may come back to causation here in a moment. It really doesn't make any sense that there are few specific, disease-modifying therapies for migraine, which affects tens of millions of people in the United States alone, right? Why is that? Why are there so few? Dr Gelfand: First of all, Dr Jones, I love it that you called it disease-modifying therapy, because that's how I think about it, too. The term, “preventive migraine therapy,” which is the more commonly used therapy, is not always really useful because - some people who have continuous headache will say, “Well, what are you trying to prevent? I've got headache all the time.” But this is really just treatments that are designed to dampen down disease activity in any form - how frequent, how long of duration, how intense - and I think it is really better conceptualized as disease-modifying therapy, so I love that you use that term. Why have there been so few? I think that it comes down to a paucity of research. Historically, NIH has underfunded migraine and other primary headache disorder research quite a bit, compared to how much disability those diseases cause in Americans each year. Hopefully, that will be getting better soon; I think there are some positive signs that that could be moving in a more positive direction. But I think, because migraine and other primary headache disorders are “invisible” illnesses - can't show you an x-ray with a broken bone; can't show you a lab readout with what your disease activity is; like you said, there's not a lot of biomarkers. Because of that, it's been hard for funders to really get behind it, and I think that's put us a little bit behind where we need to be. More research will lead to more therapies. Dr Jones: Let's hope so. It certainly is very common and affects, again, millions upon millions of people and leads to impaired quality of life and disability, as you point out. You are also the editor-in-chief of a leading journal in your field, Headache. I know many of our listeners who are neurologists and perhaps interested in editorial work as a career path might be curious - what led you to that, and how has it helped you as a clinician (being in that role)? Dr Gelfand: Yeah - I love being the editor of Headache. It's the journal of the American Headache Society. I think it's where the most interesting new science and work in headache medicine is coming out of. I have always found that reading helps me learn. If I want to learn about a topic, I need to read about it and I need to synthesize everything I read about. Being an editor makes that so accessible and fun. I really enjoy reading all of the articles that are coming in. It really helps me to think about everything I know, and thought I knew, in the field. And keeps my mind really questioning – do I really know that that's true or did I just think that's true? - and now this new data shows me that, actually, it's something else. And I really enjoy being challenged that way, on a daily basis, by new science that's coming in. So for anybody out there who has an interest in editing and playing an editorial role, I definitely encourage you to pursue that. There are programs - I know that the Green Journal has a resident and fellow section; that's where I started out, and I really had a wonderful experience in that. And then in our journal, in Headache, we have an assistant editor program for junior people - residents, fellows, postdocs - people who want to learn more about how to be an editor. I think that you learn so much about how to be a better writer, how to be a better scientist, how to communicate your findings in the most effective way. It's just invaluable and it's very fun. Dr Jones: It is kind of selfishly fun, isn't it? Dr Gelfand: Right, right. Dr Jones: Yeah, and it's important work, obviously - to put good information out into the world. At Continuum, we also have - on our editorial board, we have two residents and fellow positions, again, for that career development. I have to ask you a really hard question here, Dr Gelfand. You mentioned you read to learn; if you had to make a choice - electronic or print - what would it be? Dr Gelfand: Electronic. I know that many journals, including ours, are having to make some of these decisions right now. But I read my PDFs and I store them so that I can come back to them and search for them, and make sure, when I'm citing them, that they actually say what I thought they said because sometimes I need to look back at that. So, I am an electronic person. How about you? Dr Jones: I think I'm print. Dr Gelfand: Uh huh. Dr Jones: And I'm just sitting here thinking, there are so many people listening to this interview, and they're screaming at their device, saying, “Electronic is the answer,” or “Print is the answer.” Like you, we want to meet our subscribers where they are, and I think neurologists are very clear in their preferences. Let's just say we'll agree to disagree, and no one is right and no one is wrong – how about that? Dr Gelfand: Fair enough - I can respect that. Dr Jones: All right. I have one more question for you. This might sound like a strange question in an interview between two neurologists talking about headache - what can you tell us about chicken farming? Dr Gelfand: Well, I'd be delighted to tell you about chicken farming. As you know, because they were squawking earlier in our chat, I've got a little flock of chickens in our backyard and they are an absolute joy in my life. One thing I can tell you is that chickens respond to the photo period (how long the daylight is in a year). Now that it's November, it's the time of year when they don't get a lot of light, so they stop laying very much. I find that between Thanksgiving and about Valentine's Day, we actually start to need to buy eggs, which makes me very sad because I love having our egg supply come completely from our chickens. But we want them to rest and so that's what they're doing. Chickens will not lay very much at this time of year. During the summer and the spring and the fall (in the earlier part of the fall), they will lay almost daily, depending on which breed and how old they are. But at this time of year, it's really quiet - really, just one or two a week, I would say, right now. Dr Jones: It sounds like a fun hobby. Hopefully the chickens don't mind that you're buying chickens in the winter, and they don't feel offended by that or jealous. Dr. Gelfand: I worry that they do. I try not to show them the grocery bags. Dr Jones: Well, Dr Gelfand, thank you so much for joining us today, and thank you for such a thorough and fascinating discussion on headache disorders from your unique position as a guest editor for Continuum, I do encourage all of our listeners to check out that issue. It's really full of phenomenal pointers on practice-changing tips and tricks for managing patients who have headache disorders. I'm really grateful for your time today. And thank you for telling me a little bit about chicken farming. Dr Gelfand: Thank you so much for having me. It was really fun. And thank you for your interest. Dr Jones: Again, we've been speaking with Dr Amy Gelfand, guest editor for Continuum's most recent issue, on headache. Please check it out and thank you to our listeners for joining today. Dr. Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practice. Right now, during our Spring Special, all subscriptions are 15% off. Go to Continpub.com/Spring2024, or use the link in the episode notes to learn more and take advantage of this great discount. This offer ends June 30, 2024.
Why are dream-inspired poems so powerful? We speak today with award-winning poet, author of multiple books, and committed activist, the dynamic Joan Gelfand. Joan shares a poem inspired by a dream called Burial, quoted in full below. She speaks about why she thinks that dream-inspired poetry can be so riveting while telling someone your dream can evoke eye-rolling and boredom. She also reads a poem about Ferlinghetti which formed the basis for an award-winning video which can be found here. Joan also gives specific advice about crafting poetry. In the second half we take three calls. First Kelly Sullivan Walden calls to ask Joan how her dreamlife has been responding to the release of her new book. Joan brings up a dream in which a friend has a business named Contagious Vulnerability. Second we get a call from Adam who shares a dream about elephant which destroys his electrical panel. I offer an alternate idea to what he shared that ChatGPT had suggested about the dream. Finally we take a call from Donna of Capitola who shares that she is an observational poet. She shares a recurring dream about a trying to find a restaurant. BIO: Joan Gelfand is an award-winning author of three collections of poetry, a chapbook of short fiction, and a novel set in a Silicon Valley startup. Also a book about how to get your book published and new this year “Outside Voices: A Memoir of the Berkeley Revolution.” Find our guest at: JoanGelfand.com Burial by Joan Gelfand You might imagine a box, Airless, close the sound of dirt clumps Falling like rain. You might imagine a mudslide Rushing down steep mountain terrain Your legs buckling. You might imagine a building, Shaken to its core, rubble tumbling Knocking you senseless. You might imagine water, too deep, A collapsed bridge, a tunnel broken. My burial was none of these. An angel chanted And I went under, alone and Unafraid. This show, episode number 251, was recorded during a live broadcast on March 23, 2024 at KSQD.org, community radio of Santa Cruz. Intro and outro music by Mood Science. Ambient music new every week by Rick Kleffel. Archived music can be found at Pandemiad.com. Many thanks to Rick Kleffel for also engineering the show and to Tony Russomano for the phones. SHARE A DREAM FOR THE SHOW or a question by emailing Katherine Bell at katherine@ksqd.org. Follow on FB and IG @ExperientialDreamwork #thedreamjournal. To learn more or to inquire about exploring your own dreams go to ExperientialDreamwork.com. The Dream Journal is produced at and airs on KSQD Santa Cruz, 90.7 FM. Catch it streaming LIVE at KSQD.org 10-11am Pacific Time on Saturdays. Call or text with your dreams or questions at 831-900-5773 or email at onair@ksqd.org. Podcasts are available on all major podcast platforms released the Monday following the live show. The complete KSQD Dream Journal podcast page can be found at ksqd.org/the-dream-journal/. Now also available on PRX at Exchange.prx.org/series/45206-the-dream-journal Thanks for being a Dream Journal listener! Available on all major podcast platforms. Rate it, review it, subscribe and tell your friends.
Shohei Ohtani doesn't have what you'd call a hard life. After all, difficult things become much easier when you have 700 million dollars. But that does little to numb the sting of having your friend steal a bunch of your earnings and lose them to a bookie. Allegedly. Gelfand has a better idea: horse racing. Bet low, bet infrequently, and try not to care regardless of the outcome. That last one's the hard part. Learn more about your ad choices. Visit megaphone.fm/adchoices
Professor and cultural psychologist Michele Gelfand's latest book, Rule Makers, Rule Breakers, explores notions of what she calls “tight” and “loose” cultures, and how each shapes us as individuals and the world around us. Tight cultures closely follow unwritten cultural norms, while those on the looser side have more latitude. Culture is complicated, she says, but understanding its nuances is key to understanding the world, Gelfand tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Episode Reference Links:Michele Gelfand Website / BioRule Makers, Rule Breakers: How Tight & Loose Cultures Wire Our World (Michele Gelfand's Book)Mindset Quiz (Quiz on Michele's Website)Threat DictionaryTight-Looseness Across the 50 United States (PNAS paper on reclassifying states from red/blue to tight/loose)The Culturally Intelligent Negotiator: The Impact on Cultural Intelligence (CQ) on Negotiation Sequences & Outcomes (Michele Gelfand & Lynn Imai Study)Differences Between Tight and Loose Cultures: 33 Nation Study (Michele's study published in Science on factors that predict strict and permissive social norms)Together From Afar: Introducing a Diary Contact Technique for Improving Intergroup Relations (US / Pakistan Study)Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/XChapters:(00:00:00) IntroductionRuss introduces Michele Gelfand and her research on the study of culture and cultural intelligence.(00:02:33) Defining CultureA working definition of culture and the invisible impact of cultural norms, values, and beliefs.(00:03:46) The Tight-Loose SpectrumThe concept of tight and loose cultures and how social norms vary across cultures.(00:06:30) Cultural Variance within and between SocietiesVariations of tight-loose norms at national, state, and organizational levels, and the role of threat in shaping these norms.(00:11:34) Cultural Intelligence in Global LeadershipHow the tight-loose spectrum and cultural studies inform leadership, and the significance of cultural intelligence (CQ) in global interactions.(00:18:59) Cultural Evolutionary MismatchImplications for global threats and societal responses.(00:23:56) Applying Cultural Insights in BusinessInsights on applying cultural understanding to improve business mergers, negotiations, and the success of expatriate assignments.(00:26:09) Enhancing Cultural IntelligenceImproving cultural intelligence and steps individuals can take to enhance their CQ and adapt to cultural differences.(00:28:48) Urban vs. Rural Cultural DifferencesTight-loose division in politics and societal contexts, and the cultural divide between urban and rural areas.(00:31:19) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/X
Subscriber-only episodeTHANK YOU FOR BEING A SUBSCRIBER In this episode we meet Robyn Gelfand, the National Program Director at She Jumps, an organization that empowers women and girls to enjoy the outdoors through hosted events, educational clinics, and fundraising climbs. She Jumps participants join for a wide variety of outdoor activities where they learn skills ranging from wilderness survival to mountaineering to outdoor medicine and more. Robyn started skiing around 3 years old in the Poconos (PA), and recalls wonderful family ski trips across New England and Colorado. Robyn started a ski club in high school as a way to get more of her friends on the snow and later joined her college ski club (go UVA! wahoo) and other outdoor activities. Robyn walks us through her career path that started in marketing, but she kept feeling the pull of the outdoors. The stars aligned, and Robyn found an opportunity at Outward Bound in Portland, Oregon. Later, Robyn transitioned to her position at She Jumps, and she gives us insights into her role, program funding and fundraising events. We also learn about the amazing variety of outdoor programs that are offered through SheJumps from junior ski patrol to outdoor survival skills. Be sure to mark your calendars, the She Jumps Snowpack Scholarship will open on Oct 1, 2024.Robyn tells us about her home mountain of Mt Hood and what makes it such a special ski area. Keep up with the Latest from She JumpsWebsite: https://www.shejumps.orgInstagram: https://www.instagram.com/shejumps/?hl=enFacebook: https://www.facebook.com/SheJumps/Keep up with the Latest from the Ski Moms!Website: www.skimomsfun.comSki Moms Discount Page: https://skimomsfun.com/discountsSki Moms Ski Rental HomesJoin the 10,000+ Ski Moms Facebook GroupInstagram: https://instagram.com/skimomsfun Send us an email and let us know what guests and topics you'd like to hear next! Sarah@skimomsfun.comNicole@skimomsfun.com
Become a Premium Subscriber and Support the Ski Moms for $3/monthIn this episode we meet Robyn Gelfand, the National Program Director at She Jumps, an organization that empowers women and girls to enjoy the outdoors through hosted events, educational clinics, and fundraising climbs. She Jumps participants join for a wide variety of outdoor activities where they learn skills ranging from wilderness survival to mountaineering to outdoor medicine and more. Robyn started skiing around 3 years old in the Poconos (PA), and recalls wonderful family ski trips across New England and Colorado. Robyn started a ski club in high school as a way to get more of her friends on the snow and later joined her college ski club (go UVA! wahoo) and other outdoor activities. Robyn walks us through her career path that started in marketing, but she kept feeling the pull of the outdoors. The stars aligned, and Robyn found an opportunity at Outward Bound in Portland, Oregon. Later, Robyn transitioned to her position at She Jumps, and she gives us insights into her role, program funding and fundraising events. We alsoSHOP IKSPLORFrom infants to grown-ups, Iksplor crafts their layers from premium 100% merino wool. Ski Moms members can save 10% off with code: SKIMOM on the Iksplor website. Discover why every adventure feels better when wrapped in the comfort of Iksplor. Hearty, yummy and perfect for wintery nights in. This digital cookbook brings the very best easy and delicious recipes for you and your family. All recipes were developed by ski moms. 36 tried and true ski mom recipes. Shop the Ski Moms Cookbook here. Head to the Ski Moms Merch shop here. As always, 10% of proceeds go to support the Share Winter Foundation. Save 20% off your Skida orders https://skida.com/discount/SKIMOMS20Skida is committed to local production, limited edition products, and a fresh perspective.Each season Skida delights old and new brand fans with whimsical prints for everyone in the family (including dogs!). Practical and pretty, layering on Skida pieces for your winter adventures feels like bringing along a friend. Support the showKeep up with the Latest from the Ski Moms!Website: www.skimomsfun.comSki Moms Discount Page: https://skimomsfun.com/discountsSki Moms Ski Rental HomesJoin the 10,000+ Ski Moms Facebook GroupInstagram: https://instagram.com/skimomsfun Send us an email and let us know what guests and topics you'd like to hear next! Sarah@skimomsfun.comNicole@skimomsfun.com
Lisa is Tom and Kathryn's neighbor. She's also the author of If My Hoo-Hah Could Talk. Despite this show being called "The Family", the whole family is only here 3/5ths of the time. There's a reason we chose one of the two days not everyone is here to talk about hoo-hahs. It also, not coincidentally, is the day Gelfand is here. Today he was in one-liner heaven. Learn more about your ad choices. Visit megaphone.fm/adchoices
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, Dave Bialke from Bialke Law, The Loop's Kevin Cusick, and psychic Ruth Lordan.
Author Joan Gelfand shares cool tales from her book, Outside Voices--a moment in time in Berkeley back in the 1970s
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, The Loop's Kevin Cusick, and psychic Ruth Lordan.
The world has a lot of problems. Where they come from depends largely on who you ask. What to do about them does too, although the answer to that one is often less definitive. Gelfand's answers to both will be revealed by the end of this episode, although you get no points for guessing them. Learn more about your ad choices. Visit megaphone.fm/adchoices
This episode of The BS Show features KQ Morning Show legend Mike Gelfand, comic Bryan Miller, and The Loop's Kevin Cusick.
In the first hour SKOR North's Judd Zulgad talks about the Wolves loss to the Pelicans and hears about Tom's lunch with Sid Hartman and Gene Simmons, KSTP's Chris Egert shares info about the early Jefferey Epstein flight log lists being released and what it means if someone's name is on the list, plus other top news stories from the day. Hour #2 has actor/director Kevin Interdonato and actor & UFC legend Frankie Edgar join the show to talk about their recent project together called "The Bastard Sons" which will be in select theaters and available on demand starting January 5th! In hour #3, we get biblical. Old testament biblical. Do you know what you aren't supposed to do on the sabbath? How many cubits are you allowed to carry something? The answer to both questions is "it doesn't matter as long as you have a wire in the sky". Then, Kristyn Burtt and the crew reminisce about the days back when movies used to exist. Or something like that. On the Family, we finally ask the question of why politicians are so greedy and selfish. I know, you've been waiting a long time for it. Rest assured, your day has come at last. We also, on a more serious note, hear Gelfand's thoughts on the passing of Pat Ebertz. He and Pat shared a special connection: being awake very, very late. Stream the show LIVE on the Tom Barnard Show app M-F from 8-12PM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
In the first hour SKOR North's Judd Zulgad talks about the Wolves loss to the Pelicans and hears about Tom's lunch with Sid Hartman and Gene Simmons, KSTP's Chris Egert shares info about the early Jefferey Epstein flight log lists being released and what it means if someone's name is on the list, plus other top news stories from the day. Hour #2 has actor/director Kevin Interdonato and actor & UFC legend Frankie Edgar join the show to talk about their recent project together called "The Bastard Sons" which will be in select theaters and available on demand starting January 5th! In hour #3, we get biblical. Old testament biblical. Do you know what you aren't supposed to do on the sabbath? How many cubits are you allowed to carry something? The answer to both questions is "it doesn't matter as long as you have a wire in the sky". Then, Kristyn Burtt and the crew reminisce about the days back when movies used to exist. Or something like that. On the Family, we finally ask the question of why politicians are so greedy and selfish. I know, you've been waiting a long time for it. Rest assured, your day has come at last. We also, on a more serious note, hear Gelfand's thoughts on the passing of Pat Ebertz. He and Pat shared a special connection: being awake very, very late. Stream the show LIVE on the Tom Barnard Show app M-F from 8-12PM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
In the first hour SKOR North's Judd Zulgad talks about the Wolves loss to the Pelicans and hears about Tom's lunch with Sid Hartman and Gene Simmons, KSTP's Chris Egert shares info about the early Jefferey Epstein flight log lists being released and what it means if someone's name is on the list, plus other top news stories from the day. Hour #2 has actor/director Kevin Interdonato and actor & UFC legend Frankie Edgar join the show to talk about their recent project together called "The Bastard Sons" which will be in select theaters and available on demand starting January 5th! In hour #3, we get biblical. Old testament biblical. Do you know what you aren't supposed to do on the sabbath? How many cubits are you allowed to carry something? The answer to both questions is "it doesn't matter as long as you have a wire in the sky". Then, Kristyn Burtt and the crew reminisce about the days back when movies used to exist. Or something like that. On the Family, we finally ask the question of why politicians are so greedy and selfish. I know, you've been waiting a long time for it. Rest assured, your day has come at last. We also, on a more serious note, hear Gelfand's thoughts on the passing of Pat Ebertz. He and Pat shared a special connection: being awake very, very late. Stream the show LIVE on the Tom Barnard Show app M-F from 8-12PM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
In the first hour SKOR North's Judd Zulgad talks about the Wolves loss to the Pelicans and hears about Tom's lunch with Sid Hartman and Gene Simmons, KSTP's Chris Egert shares info about the early Jefferey Epstein flight log lists being released and what it means if someone's name is on the list, plus other top news stories from the day. Hour #2 has actor/director Kevin Interdonato and actor & UFC legend Frankie Edgar join the show to talk about their recent project together called "The Bastard Sons" which will be in select theaters and available on demand starting January 5th! In hour #3, we get biblical. Old testament biblical. Do you know what you aren't supposed to do on the sabbath? How many cubits are you allowed to carry something? The answer to both questions is "it doesn't matter as long as you have a wire in the sky". Then, Kristyn Burtt and the crew reminisce about the days back when movies used to exist. Or something like that. On the Family, we finally ask the question of why politicians are so greedy and selfish. I know, you've been waiting a long time for it. Rest assured, your day has come at last. We also, on a more serious note, hear Gelfand's thoughts on the passing of Pat Ebertz. He and Pat shared a special connection: being awake very, very late. Stream the show LIVE on the Tom Barnard Show app M-F from 8-12PM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
Merry Christmas! No interview today. No monologue either. Just a simple, short and sweet song I wanted to give as a gift to anyone whose heart is hurting this holiday.Why I'm sharing this song with you:Since Christmas has fallen on a Monday this year, and I always release new episodes on Monday, I faced a dilemma. I thought it would be a disservice to any guest to ask them to do an episode that would air on a day that the average listener can be expected to have other priorities, and I didn't want to interrupt anyone's holiday with a silly request to listen to an interview instead of celebrating traditions with their loved ones. At the same time, I didn't want to lose the consistency of releasing one episode per week, which I've been doing since the podcast launched in May of 2022. A few weeks before Christmas, this beloved song came to me and said, "hey! Share me with your listeners for Christmas! I'm the perfect gift for your audience!" And I thought, that's perfect. So I reached out to the artist, got in touch with his licensing company, and shelled out the dollars for the rights to share this song with you as my way of saying thank you for supporting the show. As you may have noticed, one of the things I like to do on this podcast is to highlight people of exceptional character and virtue. Ryan O'Neal, who goes by the artist name Sleeping at Last, is one such individual, and I simply adore him. His thoughtfully composed, exquisite music has gotten me through hard times, inspired and soothed me. Beyond mere auditory pleasure, though, his virtuous character shines through everything he touches. For example, this series he did on the Enneagram shows the tremendous amount of effort he puts in to empathizing with the human experience, taking perspectives and telling stories through sound. As an Enneagram One myself - as I discussed with Kim O in episode 80 - it's crucial to my own mental health that I surround myself with examples of virtuous character, good deeds, exquisitely crafted art, and things just generally being done really well. It helps me feel less alone in the universe, less uniquely burdened with the impossible task of bringing out the best in everyone and everything. Ryan is one of those people who seems to be well along his path of self-actualization, who strives to manifest his character and virtue through everything he touches. It seems clear that he is a well-rounded person, a loving husband, father, and friend to many. His music is heartfelt, therapeutic, soulful, and deeply empathic. May this song touch your heart as it touches mine, and bring comfort to the darkness of the winter season. Lyrics to Snow, by Sleeping at Lastthe branches have traded their leaves for white sleeves all warm-blooded creatures make ghosts as they breathe scarves are wrapped tightly like gifts under trees christmas lights tangle in knots annuallyour families huddle closely betting warmth against the cold but our bruises seem to surface like mud beneath the snowso we sing carols softly, as sweet as we know a prayer that our burdens will lift as we go like young love still waiting under mistletoe we'll welcome december with tireless hopelet our bells keep on ringing making angels in the snow may the melody disarm us when the cracks begin to showlike the petals in our pockets may we remember who we are unconditionally cared for by those who share our broken heartsthe table is set and our glasses are full though pieces go missing, may we still feel whole we'll build new traditions in place of the old ‘cause life without revision will silence our soulsso let the bells keep on ringing making angels in the snow may the melody surround us when the cracks begin to showlike the petals in our pockets may we remember who we are unconditionally cared for by those who share our broken heartsas gentle as feathers, the snow piles high our world gets rewritten and retraced every time like fresh plates and clean slates, our future is white new year's resolutions will reset tonightMusic and lyrics by Ryan O'Neal/Sleeping at LastLicensing thanks to Gelfand, Rennert, & Feldman LLCFollow Sleeping at Last on SpotifyFollow The Sleeping at Last Podcast on SpotifyLearn about how the artist was inspired to create this song. Read what he wrote in 2011, or listen to episode 8 of The Sleeping at Last Podcast, which Ryan recorded in 2017, in which he elaborates on his songwriting process for Snow. To support this show, please leave a rating & review on Apple, Spotify, or wherever you get your podcasts. Subscribe, like, comment & share via my YouTube channel. Or recommend this to a friend!Learn more about Do No Harm.Take $200 off your EightSleep Pod Pro Cover with code SOMETHERAPIST at EightSleep.com.Take 20% off all superfood beverages with code SOMETHERAPIST at Organifi.Check out my shop for book recommendations + wellness products.Show notes & transcript provided with the help of SwellAI.Special thanks to Joey Pecoraro for our theme song, “Half Awake,” used with gratitude and permission.Watch NO WAY BACK: The Reality of Gender-Affirming Care (our medical ethics documentary, formerly known as Affirmation Generation). Stream the film or purchase a DVD. Use code SOMETHERAPIST to take 20% off your order. Follow us on X @2022affirmation or Instagram at @affirmationgeneration.Have a question for me? Looking to go deeper and discuss these ideas with other listeners? Join my Locals community! Members get to ask questions I will respond to in exclusive, members-only livestreams, post questions for upcoming guests to answer, plus other perks TBD. ★ Support this podcast on Patreon ★
Tom, Brittany, and Tevin hear from an old friend as Phillip Wise joins the show! In the first hour, former co-host Phillip Wise joins the show before his move out of state to catch up with the crew! Hour #2 includes Kristyn Burtt speaks on Amazon's new Prime Video series "Gen V", and KSTP's Chris Egert informs about outrage on Lifetime Fitness' plans to make changes to senior memberships. In hour #3, Rock and Roll Hall of Famer and lead guitarist for Genesis, Steve Hackett, joins the show and Mike Gelfand stops by the studio! Stream the show LIVE on the Tom Barnard Show app M-F from 7-10AM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
Tom and Brittany are joined in studio by Mike Gelfand on today's show! In the first hour, Doug Sprinthall helps find new alternative words to use in everyday conversation. Hour #2 includes Kristyn Burtt talks about the big development that network CEOs have show up to negotiations with the WGA, and KSTP's Chris Egert on a local prostitution ring getting busted. In hour #3, Mike Gelfand stops by the studio and Jeff Passolt tells the story of how he set the SCSU hockey record for most PIM in a single game! Stream the show LIVE on the Tom Barnard Show app M-F from 7-10AM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
Tom and Brittany are joined in-studio by the terrific Mike Gelfand! In the first hour, auto legend Doug Sprinthall joins the show to talk about Elvis Presley and more. Hour #2 includes Kristyn Burtt on Amazon's new feature called Prime Premiere, and KSTP's Chris Egert on Minnesota marijuana news. In hour #3, legendary Minnesota news anchor Jeff Passolt joins the show to talk Vikings and old broadcasting stories, plus Mike Gelfand stops by the studio Stream the show LIVE on the Tom Barnard Show app M-F from 7-10AM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
Don Shelby is in hosting with Tom out, joined as always by Brittany Arneson and Mike Gelfand drops by the studio! In the first hour, Don and Brit swap military stories with Don sharing a time he outsmarted a Sergeant, and it turns out Brit may be the best baker of all-time? Hour #2 includes Kristyn Burtt on the big battle between Disney and Spectrum, and KSTP's Chris Egert explains what's clogging the plumbing at local schools. In hour #3, SKOR North's Judd Zulgad joins us, Mike Gelfand stops by the studio, and Ali Matta chimes in from Chicago. Stream the show LIVE on the Tom. Barnard Show app M-F from 7-10AM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices
Tom has been called away to loftier endeavors, so today's show is just Andy and Gelfand talking about their health problems. Just kidding. Josh Arnold swoops in to save the day with a topic that's equally serious but much more pleasant: money. Sometimes you get more, like when you invest wisely. Sometimes you don't, like when you gamble. Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2025 Ivy Podcast Discovery LLC
